Augurex Announces Mayo Clinic Laboratories Now Offering 14-3-3eta Testing for Rheumatoid Arthritis
Mayo Clinic Laboratories adds 14-3-3eta serum testing to its diagnostic testing portfolio, expanding access to an important biomarker for rheumatoid arthritis VANCOUVER, British Columbia — Augurex Life Sciences Corp., a commercial-stage diagnostics company focused on autoimmune and inflammatory diseases, today announced that Mayo Clinic Laboratories is now offering 14-3-3eta serum testing for…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
